U.S. Markets closed

Humana most exposed to Medicare Advantage among insurers, says Cantor

Cantor believes that last week's announcement of higher than expected Medicare Advantage rates for FY14 leaves health insurers poised to report stronger results in 2014. The firm thinks the rate announcement bodes well for sentiment towards the group and it reiterates a $90 price target and Buy rating on Humana.